September 10th, 2021

Psychoactive Podcast: The E-cigarette revolution - vaping, nicotine and harm reduction

I had an excellent conversation with Ethan Nadelmann, the founder of the New York-based Drug Policy Alliance for his outstanding Psychoactive podcast series about all aspects of drugs and drugs policy, which I highly recommend.

In this episode, “The E-cigarette revolution”, we covered vaping, nicotine, harm reduction – science, policy, politics and controversy – with Ethan as host putting the challenging questions.   Listen via your usual podcast provider (search on Psychoactive)… or via these links.

>> read the full post

image_pdfPrintable/PDF version
September 8th, 2021

CHEST journal point and counterpoint - E-cigarette use for harm reduction in tobacco use disorder: Yes/No?

A debate about the merits of e-cigarettes for tobacco harm reduction

The September 2021 edition of CHEST, the respiratory journal, features a point/counterpoint debate on the value of e-cigarettes for tobacco harm reduction.  I am making the case in favour (the Point) and Dr Hasmeena Kathuria (Boston University) and Dr Frank T. Leone (University of Pennsylvania) are making the case against (the Counterpoint).  We each provide a shorter rebuttal to the arguments made by the other.  We also recorded a 30-minute podcast to air these arguments face-to-face.  Recognising the broader interest in the subject, CHEST has kindly made this content open access so far.

Whatever you think of the respective arguments, it was refreshing to find a forum willing to air them in a respectful and measured way, I am grateful to Drs Kathuria and Leone for engaging and making their case and to CHEST for providing the platform.  I wish we could have much more debate like this.

For ease of access, I have added the relevant links below.

>> read the full post

image_pdfPrintable/PDF version
September 7th, 2021

Will FDA harm health, destroy businesses, and protect the cigarette industry through regulatory overkill? A preview.

This blog gives my take on how to think about the FDA’s decisions (some taken, some forthcoming) on approving or denying thousands of “pre-market tobacco applications” (PMTAs) to allow vaping products to remain on the US market.  FDA must make decisions no later than 9th September 2021, following legal action brought against the agency. FDA’s Director of the Center for Tobacco Products, Mitchel Zeller, provides the background in a February 2021 blog.

There’s a lot to be written on this, but I will settle for 16 observations and questions that will shape my take on FDA’s announcements.

>> read the full post

image_pdfPrintable/PDF version
September 2nd, 2021

Health Canada consults on the really dumb idea of making vaping a less appealing alternative to smoking

Health Canada is trying to ban almost all vaping liquid flavours. This is on top of measures to limit nicotine strengths and marketing. It is the nearest they can get to a prohibition without actually having to prohibit the most promising low-risk rival to cigarettes. The likely effects are obvious: more smoking. But in a bizarre twisting of reality and evidence, Health Canada finds that making vaping less attractive relative to smoking will… um … reduce smoking. And that’s how it justifies the measure.  We respond with a counter-analysis.

>> read the full post

image_pdfPrintable/PDF version
May 31st, 2021

Letter: WHO must urgently reassess its tobacco & nicotine policy and stop causing harm

WHO should be building public trust, not giving its critics further justification

It’s World No Tobacco Day and we have sent our detailed letter and multiple critical expert comments to the WHO Director-General.   The covering note and links to relevant documents are reproduced below.  I hope it causes them to pause and reflect.  My guess is that Tedros has been very badly advised here.

>> read the full post

image_pdfPrintable/PDF version